IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.182
EU - Europa 6.499
AS - Asia 1.493
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 10
OC - Oceania 8
AF - Africa 6
Totale 16.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.167
IE - Irlanda 1.737
UA - Ucraina 1.398
IT - Italia 1.062
SE - Svezia 704
HK - Hong Kong 697
VN - Vietnam 479
FI - Finlandia 364
DE - Germania 350
RU - Federazione Russa 315
CN - Cina 176
FR - Francia 141
GB - Regno Unito 118
RO - Romania 74
TR - Turchia 60
CH - Svizzera 55
AT - Austria 37
BE - Belgio 34
NL - Olanda 27
UZ - Uzbekistan 22
GR - Grecia 21
PL - Polonia 21
SG - Singapore 19
CA - Canada 13
CZ - Repubblica Ceca 13
EU - Europa 11
LB - Libano 11
ES - Italia 9
JP - Giappone 8
AU - Australia 6
BR - Brasile 6
EG - Egitto 6
IR - Iran 6
AM - Armenia 5
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
TW - Taiwan 3
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AZ - Azerbaigian 1
ID - Indonesia 1
IL - Israele 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
Totale 16.209
Salva come PNG Salva come JPEG
Città #
Chandler 1.966
Dublin 1.736
San Mateo 850
Jacksonville 745
Hong Kong 694
Dong Ket 479
Altamura 474
Medford 405
Princeton 402
Wilmington 357
Lawrence 355
Perugia 286
Ann Arbor 259
Des Moines 247
Andover 184
Beijing 152
Saint Petersburg 121
Ashburn 112
San Paolo di Civitate 94
Falls Church 93
Helsinki 73
Norwalk 73
Woodbridge 66
Izmir 58
Boardman 55
Redmond 54
Timisoara 35
Brussels 34
Bucharest 34
Redwood City 27
Houston 24
New York 24
Rome 23
Moscow 22
Den Haag 20
Lausanne 19
Auburn Hills 17
Fairfield 17
Los Angeles 16
Frankfurt Am Main 14
Saint Louis 11
Shanghai 10
Milan 9
Paris 9
San Diego 9
Tappahannock 9
Chicago 8
Lappeenranta 7
Seattle 7
Ardabil 6
Madrid 6
Monmouth Junction 6
Tokyo 6
Toronto 6
Bologna 5
Florence 5
Fremont 5
Mcallen 5
Singapore 5
Adelaide 4
Cava de' Tirreni 4
Hanover 4
Ottawa 4
Philadelphia 4
Terni 4
Yerevan 4
Amsterdam 3
Bratislava 3
Cambridge 3
Duino-Aurisina 3
Edinburgh 3
El Paso 3
Giza 3
Kiev 3
Lissone 3
Radeberg 3
Saronno 3
Sesto Fiorentino 3
Turin 3
Vienna 3
Aprilia 2
Arlandastad 2
Assisi 2
Austin 2
Bad Tatzmannsdorf 2
Barcelona 2
Bogotá 2
Brixen 2
Ceska 2
Cinisello Balsamo 2
Damietta 2
Dearborn 2
Frankfurt am Main 2
Genoa 2
Göttingen 2
Hamburg 2
Ludwigshafen 2
Massarosa 2
Montesilvano Marina 2
Nagold 2
Totale 10.960
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 111
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 109
A new assay for antiphospholipid antibodies in patient with ischemic stroke 102
Platelet MAO-B activity and vitamin B12 in old age dementias. 96
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 91
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 87
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 86
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 85
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 84
a-D-Mannosidses in patients with familial Alzheimer's Disease 81
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 81
a-D-Mannosidases in patients with Alzheimer's disease 80
Swalloving dysfunction: neurovascolar- anatomical correlation. 79
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 74
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 73
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 73
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 72
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 71
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 71
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 70
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 69
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 69
Vascular cognitive impairment: a pragmatic concept 68
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 68
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 68
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 67
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 67
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 67
Blood pressure and functional aspects of the aging brain. 67
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 66
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 66
The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration. 66
Cerebrospinal fluid biomarkers in Parkinson disease. 66
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 65
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 65
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 64
Brain SPECT in the diagnosis of degenerative dementia. 64
Early admission to stroke unit influences clinical outcome 64
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 64
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 63
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 63
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. 62
Brain SPECT in pathological aging brain: Lewy Body Disease and Age-Associated Memory Impairment. 62
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 62
Association between migraine and headache attributed to stroke: a case-control study. 61
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 61
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 60
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 60
Acetyl-L-carnitine in the treatment of mildly demented elderly patients. 60
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 60
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 60
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 60
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 59
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 59
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 59
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 59
Hippocampal epileptogenesis in autoimmune encephalitis 59
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 58
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 58
Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid. 58
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 58
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study. 58
Lysosomal enzymes in Parkinson's disease 58
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease. 57
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 57
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 57
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 57
White matter changes in stroke patients. Relationship with stroke subtype and outcome. 56
Activation of complement and contact system in Alzheimer’s disease 56
Carotid atherosclerotic disease: role of hypertension and other risk factors. 56
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 56
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 56
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 56
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 55
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 54
Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment. 54
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 54
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 54
A magnetization transfer study of mild and advanced Parkinson's disease. 54
Is multi-infarct dementia representative of vascular dementias? A retrospective study 53
Pathogenetic mechanisms in vascular dementia. 53
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. 53
Arterial hypertension and stroke prevention: an update. 53
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 52
Atrial fibrillation and stroke. 52
Lysosomal enzyme activities in human brain 52
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 51
Brain SPECT in different dementia disorders: AD, Possible AD, Preclinical AD, AAMI, FTD, LBD, VaD, secondary dementia. 51
Method for Diagnosis 51
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 51
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 51
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 51
Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers. 50
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 50
[Drinking-water and cardiovascular mortality]. 50
Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group. 50
Platelet MAO-B activity and vitamin B12 in old age dementias. 50
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 50
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 49
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 49
Totale 6.334
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201999 0 0 0 0 0 0 0 0 0 13 84 2
2019/20201.384 26 12 205 9 199 12 239 35 281 139 77 150
2020/20213.135 16 204 90 217 989 137 202 39 340 123 240 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20241.553 184 280 126 59 27 14 463 97 273 30 0 0
Totale 17.033